Evonik shares fall over 5% as Q2 results meet views but guidance trimmed

Published 01/08/2025, 06:28
Updated 01/08/2025, 12:38
© Reuters.

Investing.com -- Evonik (ETR:EVKn)shares dropped more than 5% on Friday after the company reported second-quarter earnings in line with expectations but lowered its full-year sales forecast and said results would likely land at the bottom of its guidance range.

Adjusted EBITDA for the quarter was €509 million, down 12% from €578 million a year earlier and matching both Jefferies and consensus estimates of €511 million. 

Group sales fell 6% year over year to €3.50 billion, missing the €3.64 billion estimate. 

The decline included a 5% organic drop (volumes -4%, prices -1%), with portfolio and currency effects reducing sales by 3% each.

Full-year adjusted EBITDA guidance of €2 billion to €2.3 billion was maintained, but the German specialty chemicals company now expects to be at the lower end of the range. 

Revenue expectations were revised down to €14 billion to €15 billion from a previous forecast of €15 billion to €17 billion. 

Free cash flow conversion guidance was held at 40%, while capital expenditure plans were reduced to €750 million from €850 million.

By division, Custom Solutions posted adjusted EBITDA of €254 million, in line with estimates but down 10% from €281 million in the prior-year quarter. 

Sales declined 7% to €1.37 billion. The company cut its full-year outlook for the segment to “slightly above prior-year level,” down from “considerably above.”

The Advanced Technologies segment delivered adjusted EBITDA of €266 million, flat year over year but 5% above estimates. 

Sales totaled €1.51 billion, nearly unchanged from the prior year. Volumes rose 1% and prices fell 1%, while portfolio and currency effects were +3% and -4%, respectively. The outlook was revised to “slightly below prior-year level” from “on prior-year level.”

In Infrastructure and Other, adjusted EBITDA swung to a €11 million loss from a €31 million profit a year earlier. 

Sales dropped 33% to €621 million. The company cited weak C4 spreads and demand. Guidance for the division was lowered to “significantly below prior-year level.”

Operating cash flow from continuing operations was negative €35 million, down from €360 million in the second quarter of 2024. 

Free cash flow was negative €211 million, compared with €217 million a year earlier. Net financial debt stood at €3.86 billion, equating to 1.8x net debt to adjusted EBITDA.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.